TOTAL VOLUME:

$134.2b

24H VOL:

$126,324,530

24H TRANSACTIONS:

2,388,728,490

OPEN INTEREST:

$1,434,646,834

406,019

Markets across

30,401

events

MATCHED EVENTS:

2,689

PLATFORM COVERAGE:

5

Polymarket:

39%

VS.

Kalshi:

61%

BETA
Dashboards
Tour
All
Sports
Manchester United vs Sabah Masazir: Second Half Spread
kalshi

Manchester United vs Sabah Masazir: Second Half Spread

Volume:
$2,699

Manchester United wins the 2H by more than 1.5 goals

 - Kalshi

Manchester United wins the 2H by more than 1.5 goals - Kalshi

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolved Sep 10, 2026

Closed: Sep 10, 4:56 PM EST

kalshi

Kalshi

View
Join Kalshi and score $25 for your first trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h
7d
Open Interest
Ends in
Result
kalshi

Manchester United wins the 2H by more than 1.5 goals

View
0%
Yes 0¢No 100¢
100¢
N/A
$2,699
N/A
N/A
$1,961
Settled
No
kalshi

Sabah Masazir wins the 2H by more than 1.5 goals

0%
Yes 0¢No 100¢
100¢
N/A
$0
N/A
N/A
$0
Settled
No
Total markets: 2

Description

This market focuses on predicting which team will dominate the second half of an upcoming Champions League soccer match between Manchester United and Sabah Masazir. Specifically, it evaluates whether either team will secure a decisive lead of more than 1.5 goals during that half. The outcome depends entirely on the performance and scoring dynamics after halftime.

Kalshi

The event determines whether Manchester United or Sabah Masazir will win the second half of their scheduled Champions League match by more than a 1.5 goal margin. If Manchester United achieves this margin, the market resolves positively for that condition. Conversely, if Sabah Masazir secures the same margin, the market resolves positively for their condition. Only goals scored in the second half count toward these outcomes. Should the originally scheduled match on September 10, 2026, be canceled or rescheduled beyond 48 hours, the market will instead resolve to a fair price, ensuring equitable treatment for all participants based on the revised circumstances.